Sign in Sign up for free

Last updated: 7 June 2024 at 6:11pm EST

Daniel Croteau Net Worth




The estimated Net Worth of Daniel C Croteau is at least $2.14 Million dollars as of 10 May 2021. Mr. Croteau owns over 1,815 units of UFP Technologies stock worth over $2,033,810 and over the last 9 years he sold UFPT stock worth over $0. In addition, he makes $110,500 as Independent Director at UFP Technologies.

Mr. Croteau UFPT stock SEC Form 4 insiders trading

Daniel has made over 2 trades of the UFP Technologies stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 1,815 units of UFPT stock worth $100,152 on 10 May 2021.

The largest trade he's ever made was buying 1,815 units of UFP Technologies stock on 10 May 2021 worth over $100,152. On average, Daniel trades about 229 units every 0 days since 2015. As of 10 May 2021 he still owns at least 6,846 units of UFP Technologies stock.

You can see the complete history of Mr. Croteau stock trades at the bottom of the page.





Daniel Croteau biography

Daniel C. Croteau serves as Independent Director of the Company. Mr. Croteau has served as a director of the Company since December 2015. Presently Mr. Croteau is the CEO of Surgical Specialties Corporation, a private equity-backed company that specializes in high performance wound closure products and surgical knives. Surgical Specialties Corporation has a global sales and marketing organization and operates manufacturing facilities in China, England, Germany, Puerto Rico, and Mexico. Mr. Croteau was the Chief Executive Officer of Vention Medical from January 2011 until March 2017, when he resigned in connection with the acquisition of Vention Medical by Nordson Corporation and the divestiture of the Vention Device Manufacturing Services business unit to MedPlast Inc. Vention Medical provides component manufacturing, assembly and design services for disposable medical devices, with fourteen facilities across the United States, Central America, Ireland and Israel. Prior to assuming his role with Vention Medical, Mr. Croteau was President of FlexMedical from July 2005 through December 2010. FlexMedical is the medical division of Flex (Nasdaq: FLEX), which provides manufacturing and supply chain services for disposable medical devices, medical equipment, and drug delivery devices. From July 2004 to June 2005, Mr. Croteau served as the Executive Vice President and General Manager of Orthopedics for Accellent (renamed Lake Region Medical in 2014 and now a division of Integer), a manufacturer of specialty components and finished medical devices used in orthopedic, cardiology, and surgical devices. From August 1999 to June 2004, Mr. Croteau served as an executive at MedSource Technologies, which was merged in June 2004 with UTI Corporation to form Accellent. As Senior Vice President at MedSource Technologies, Mr. Croteau was responsible for sales, marketing, strategy and acquisitions. Prior to entering the medical device industry in 1999, Mr. Croteau spent the majority of his career in various roles at General

What is the salary of Daniel Croteau?

As the Independent Director of UFP Technologies, the total compensation of Daniel Croteau at UFP Technologies is $110,500. There are 14 executives at UFP Technologies getting paid more, with R. Jeffrey Bailly having the highest compensation of $2,325,980.



How old is Daniel Croteau?

Daniel Croteau is 54, he's been the Independent Director of UFP Technologies since 2015. There are 12 older and 2 younger executives at UFP Technologies. The oldest executive at UFP Technologies Inc. is Cynthia Feldmann, 67, who is the Independent Director.

What's Daniel Croteau's mailing address?

Daniel's mailing address filed with the SEC is C/O UFP TECHNOLOGIES, INC., 100 HALE STREET, NEWBURYPORT, MA, 01950.

Insiders trading at UFP Technologies

Over the last 21 years, insiders at UFP Technologies have traded over $115,201,423 worth of UFP Technologies stock and bought 293,413 units worth $1,574,519 . The most active insiders traders include R Jeffrey Bailly, Peter R Worrell, and Richard L Bailly. On average, UFP Technologies executives and independent directors trade stock every 22 days with the average trade being worth of $4,358,758. The most recent stock trade was executed by Ronald J Lataille on 23 August 2024, trading 2,392 units of UFPT stock currently worth $787,064.



What does UFP Technologies do?

ufp technologies is a producer of innovative custom-engineered components, products, and specialty packaging. founded in 1963 and headquartered in newburyport, massachusetts, our company has pioneered a long list of processes and applications, has a large portfolio of active patents, and holds proprietary positions on many advanced materials from leading global suppliers. with a deep and accomplished engineering team, ufp technologies is a critical link in the value chain between raw material suppliers and oems. our team acts as an extension of customers'​ in-house research, engineering and manufacturing groups, working closely with them to solve their most complex product and packaging challenges. using foams, plastics, composites, and natural fiber materials, we design and manufacture a vast range of solutions primarily for six target markets including medical, automotive, aerospace & defense, electronics, consumer and industrial.



What does UFP Technologies's logo look like?

UFP Technologies Inc. logo

Complete history of Mr. Croteau stock trades at UFP Technologies

Date
#
Company
 Insider
Trans.
Transaction
 Shares Price per share Total value Shares after Source
10 May 2021 UFPT UFP Technologies Inc. Daniel C Croteau
Director
 Buy 1,815 $55.18 $100,152
10 May 2021
6,846 ↗
6 May 2021 UFPT UFP Technologies Inc. Daniel C Croteau
Director
 Buy 935 $53.35 $49,882
6 May 2021
5,031 ↗


UFP Technologies executives and stock owners

UFP Technologies executives and other stock owners filed with the SEC include: